In partnership with

Anna's Daybreak News

_{Just facts, you think for yourself}

Monday, 5:09 AM

March 2, 2026

Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

War in Iran

The U.S. and Israel launched Operation Epic Fury, striking Iranian military sites and killing over 40 officials, including top defense leaders.

Ayatollah Ali Khamenei, Iran’s supreme leader for 37 years, was among the killed, leaving a power vacuum with no clear successor. A temporary three-person council now leads Iran, while the Assembly of Experts will select the next leader, likely a symbolic figure.

Iran retaliated with missile and drone attacks against U.S. forces and allies, killing civilians and U.S. personnel. Iran closed the Strait of Hormuz, disrupting global oil shipments.

Iran’s regime remains resilient, having endured the killing of many commanders last year without collapsing. Protests inside Iran persist but lack unified leadership.

Sources: WallStreetJournal, AP News, BBC, Economist

Austin Terror Shooting

A gunman identified as Ndiaga Diagne opened fire near Buford’s bar in downtown Austin, killing two and injuring 14, with three critically wounded.

The attacker fired from an SUV before exiting and shooting with a rifle. Police engaged and fatally shot him within 57 seconds of arrival. The suspect, a naturalized U.S. citizen from Senegal, showed possible terrorist links, though no motive is confirmed.

The FBI continues its investigation. Texas Governor Greg Abbott ordered increased infrastructure patrols following the attack, which affected an entertainment district near the University of Texas campus.

Authorities emphasized prompt response prevented more casualties amid heightened U.S.-Iran tensions.

Sources: AP News, WallStreetJournal, BBC, NYTimes

OpenAI-Pentagon AI Deal

OpenAI secured a $200 million Pentagon contract to deploy AI models under strict safeguards, banning mass domestic surveillance, autonomous weapons, and high-stakes automated decisions.

AI is delivered exclusively via cloud APIs with continuous human oversight and proprietary safety controls to prevent misuse. The deal, described by CEO Sam Altman as “rushed,” complies with Executive Order 12333, raising privacy concerns.

Anthropic was excluded after failed talks and a Trump directive phasing out its technology over supply-chain risks. The Pentagon insists on “all lawful purposes” use, causing friction with some firms. Industry experts debate the ethics of military AI.

Concurrent U.S. security concerns include Middle East conflicts and a terrorism-investigated mass shooting in Austin.

Sources: TechCrunch, AXIOS, Cryptorank, Mezha

Block’s 4,000 Layoffs

Block Inc. cut 4,000 jobs last week, nearly half its workforce, citing AI-driven efficiency. The staff had grown from 3,835 in 2019 to 12,985 in 2023, then declined to 10,210 by 2025.

Block’s stock dropped about 40% since early 2025 but rose 15% after layoffs. Experts debate whether AI or pandemic-era over-hiring drove cuts. Surveys show 77% of people fear AI threatens humanity; 72% of S&P 500 companies flagged AI risks in 2025.

Goldman Sachs estimates AI cuts 5,000–10,000 U.S. tech jobs monthly. Verizon cut 13,000 jobs but denied AI caused them, launching a $20 million reskilling fund. Industry outlook remains uncertain amid transformation.

Sources: WallStreetJournal, Bloomberg

Miracle Toothpaste

Researchers developed a toothpaste containing guanidinoethylbenzylamino imidazopyridine acetate that inhibits harmful bacteria causing gum disease, like Porphyromonas gingivalis, without killing beneficial oral microbes.

Unlike traditional mouthwashes that disturb the oral microbiome and allow harmful bacteria to rebound, this compound stabilizes bacterial balance by blocking harmful growth. The toothpaste also includes fluoride and abrasives for cavity prevention.

Safety tests confirmed no side effects or bloodstream absorption. Originating from a 2018 EU project, the product meets Good Laboratory Practice standards and is marketed by PerioTrap Pharmaceuticals GmbH.

PerioTrap also offers a care gel post-dental cleaning and plans mouthwash and veterinary products to maintain gum health.

Sources: SciTechDaily

Metabolic Weakness in Cancer Cells

Researchers identified how some cancer cells bypass glutamine dependence by using pyruvate and the mitochondrial enzyme pyruvate carboxylase, which requires vitamin B7 (biotin) to function.

Without vitamin B7, cancer cell growth stops. Mutations in the FBXW7 gene reduce pyruvate carboxylase levels, restoring glutamine dependence. This explains resistance to anti-glutamine therapies, as cancer cells switch metabolic pathways involving pyruvate and vitamin B7.

Targeting vitamin B7 pathways and FBXW7 mutations may enhance cancer treatment by blocking multiple metabolic routes.

The study employed advanced metabolomics and proteomics to uncover these findings, offering new therapeutic opportunities against tumor metabolic adaptation.

Sources: SciTechDaily

“You don't want to grip your opinions so tight that you cut off the circulation.”

Baked with love,

Anna Eisenberg ❤️